Navigation Links
New Data Demonstrate Longer-Term Safety Profile of Esbriet®
Date:9/26/2011

about InterMune, please visit www.intermune.com.

Esbriet® is a registered trademark of InterMune, Inc.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to the commercial launches of Esbriet® (pirfenidone) in the EU.  All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information.  InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.  

Other factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the Securities and Exchange Commission (SEC) (the "Form 10-K"), and other periodic reports filed with the SEC, including but not limited to the following: (i) risks related to our ability to successfully launch and commercialize Esbriet in the EU, including successfully establishing a commercial operation in the EU and receiving favorable governmental pricing and reimbursement approvals in each EU country; (ii) risks related to the regulatory process for the company's product candidates, including the possibility that the results of the new 52-week Phase 3 clinical trial (ASCEND) having an FVC endpoint may not be satisfactory to the FDA for InterMune to receive regulatory approval for pirfenidone in the United States; (iii) risks related to the uncertain, lengthy and expensive clinical developm
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
2. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
3. Germgard Lighting Demonstrates the Worlds Most Effective Hand Sterilizer to Protect Against Contagion
4. NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
5. New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent
6. Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
7. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
8. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
9. Topaz Pharmaceuticals Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs
10. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
11. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... announce the chairman of the Summit Mr. Phani Bidarahalli ... will be joined by the expert speaker faculty including senior ... May 11 – 12, at The Hotel Kabuki in ... is available for download on the event website, which can ...
(Date:5/5/2015)... 2015  Accuray Incorporated (Nasdaq: ARAY ), announced today ... of America Merrill Lynch 2015 Healthcare Conference in ... 2015 at 2:20pm PT.   A live ... Investor Relations page of the Company,s website at ... begin approximately one hour after the conclusion of the ...
(Date:5/5/2015)... Mass. , May 5, 2015  Image Stream ... a new agreement with MedAssets, one of the largest ... in the United States.  Under terms of the three-year ... accessories, and services will be made available to MedAssets ... announcing the partnership, Image Stream Medical CEO Eddie ...
Breaking Medicine Technology:Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Image Stream Medical Announces Agreement with MedAssets 2
... Sept. 19, 2011 Visual Healthcare Corp. (the "Company") (PINKSHEETS: ... and financial results. These are available on the OTC Markets ... www.visualhealthcarecorp.com . The Company is pleased to ... a major turnaround as the Company moves toward establishing a ...
... Markets Group Inc. (OTCQX: OTCM), the company that ... trade unlisted stocks, today announced that EpiCept Corp. ... trading on the OTC market,s highest tier, OTCQX®. ... on the OTC market,s prestigious tier, OTCQX U.S. Investors ...
Cached Medicine Technology:Visual Healthcare Corp. Files Year-End Disclosure Statement 2EpiCept Corp. Joins OTCQX 2
(Date:5/5/2015)... New York (PRWEB) May 05, 2015 ... ( http://www.testosteronelawsuithub.com/ ) filed on behalf of ... due to their use of prescription testosterone ... the federal multidistrict litigation underway in U.S. ... to court documents dated May 1st, defendants ...
(Date:5/5/2015)... Stamford, CT (PRWEB) May 05, 2015 Sunny ... at Cove Island Park as nearly 400 runners and walkers ... & Run,” raising nearly $35,000. , The 5K ... increase awareness about Lyme disease and to raise funds for ... combined event created by the recent merger of ...
(Date:5/5/2015)... In a April 25, 2015, report published in ... Missouri State Highway Patrol (MSHP) announced that Indiana led the ... the second year in a row. , The MSHP, ... incidents in 2014 alone, around 15% of the national total. ... US Population calls Indiana home, according to the report. , ...
(Date:5/5/2015)... The brains of people with type ... with slower information processing, according to research led by ... Health . , The findings indicate that clinicians ... for cognitive difficulties. If progressive, these changes could influence ... by the National Institutes of Health (NIH), ...
(Date:5/5/2015)... Hollywood, California (PRWEB) May 05, 2015 ... in Downtown Los Angeles, CA, Choices Recovery sponsored Durkin ... Debbie Durkin, LA’s leading producer of sustainable product placement ... some of the world’s top providers of ecologically sound ... is a premier red carpet event that makes appearances ...
Breaking Medicine News(10 mins):Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2
... Affiliated Computer,Services, Inc. (NYSE: ACS ) announced ... million contract to provide information technology,outsourcing (ITO) services ... hospital system., Under the terms of the ... center operations, network,monitoring and management, asset tracking, and ...
... of surgery a patient with kidney cancer receives depends ... tumor size, demographic characteristics, or general medical health. The ... not be receiving the most appropriate surgical care. The ... of CANCER, a peer-reviewed journal of the American Cancer ...
... Fiduciary, Media, Network ... Security and Data Privacy Coverage, ... (NYSE: DR ) has introduced a new,multi-coverage corporate ... comprehensive policy, Darwin has integrated the,following coverage parts, which ...
... Researchers at Johns Hopkins have discovered that two clinically ... same disorder. Reporting in the April issue of Nature ... class of disorders, the total number and strength of ... generate a range of symptoms wide enough to appear ...
... evident 3 months later, study finds , , SATURDAY, March ... and other menopausal symptoms in breast cancer survivors, a ... who,d had early stage breast cancer took part in ... assigned to a control group. All the women self-reported ...
... workers had more stress, less commitment and higher levels ... Persistent criticism, belittling comments, bullying and other forms of ... sexual harassment, according to a Canadian study. , ... may be more attuned to helping victims, who may ...
Cached Medicine News:Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 2Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 3Health News:Kidney cancer surgery often determined by surgeons' practice style, not medical factors 2Health News:Darwin Introduces New Managed Care Corporate Liability Insurance 2Health News:Darwin Introduces New Managed Care Corporate Liability Insurance 3Health News:Genetic research unveils common origins for distinct clinical diagnoses 2Health News:Yoga Eases Menopause Symptoms in Breast Cancer Survivors 2Health News:Aggression on Job More Harmful Than Sexual Harassment 2
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
... Respiratory Products, ,Westmed designs, manufacturers and ... and Respiratory professionals. Our mission is to ... clinician's ability to deliver quality medical care ... line. , ,Our web site is ...
... achieves optimum lung penetration for maximum therapeutic ... 1.04-1.10 µ at 6-8 LPM. Latex-free components. ... ,As the world leader in airway management ... of proven technology by offering top brands ...
... medication nebulizer achieves optimum lung penetration for ... range is 1.04-1.10 µ at 6-8 LPM. ... outlet., ,As the world leader in ... the assurance of proven technology by offering ...
Medicine Products: